Molecular diagnosis is performed at the gene level with nucleic acids as the object for detection, with high sensitivity and accuracy.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

BioMrieux, the international leader in in vitro diagnostics, today announced the acquisition of a controlling stake in Suzhou Hybiome Biomedical Engineering Co. Ltd. The company announced in July 2018 that it had acquired a minority stake in

NEW YORK (GenomeWeb) Illumina plans to acquire Pacific Biosciences for approximately $1.2 billion in cash, the companies said on Thursday. Under the agreement, which has been approved by both companies boards of directors, Illumina will pay

This story has been amended to correct errors and remove references to unrelated legal cases. NEW YORK (GenomeWeb) A jury has awarded Bio-Rad Laboratories $23.9 million in damages in the firms patent infringement suit against 10x Genomics,

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently . Fresh off its initial public offering in August , in which it raised $23.7 million in gross proceeds, the San Diego-based DNA analysi

PerkinElmer Genomics has chosen BioDiscoverys NxClinical software for genomic data analysis for its services, BioDiscovery announced recently . The software will enable PerkinElmer Genomics to provide fast and accurate copy number variation

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology co

Danaher today reported a 7 percent year-over-year increase in its third quarter revenues with its diagnostic revenues up 3 percent. For the three months ended Sept. 28, 2018, the Washington-based conglomerate tallied $4.85 billion in total r

Agena Biosciences and DaRui Biotechnology announced today that Agenas MassArray system has been cleared by the China Food and Drug Administration. The system is a mass spectrometry-based platform that Agena acquired from Sequenom in 2014 for

The global hemostasis/coagulation analyzers market was valued at USD 3.65 billion in 2017 and is expected to grow at a CAGR of 9.9% over the period 2018 to 2026 to reach USD 9.55 billion by 2026, driven mainly by the growing incidence of blo

A clinical assay from Zeesan Biotech to detect and identify 14 high-risk genotypes of human papillomavirus has been approved by the China State Food and Drug Administration, company announced recently. The MeltPro High Risk HPV test, which w